Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Vivus, Arena, Or Orexigen - Which Will Win The Anti-Obesity Market Share Race?
Seeking Alpha
Tue, 03/24/15 - 08:30 am
Tags:
Vivus, Orexigen, Arena Pharmaceuticals, Contrave, Belviq, Qsymia, obesity
Vivus: Teva Wants To Make Generic Qsymia - Can This Be Good?
Seeking Alpha
Wed, 03/11/15 - 03:17 pm
Tags:
Vivus, Teva Pharmaceutical, generics, Qsymia
Vivus' Suit Against Actavis Gets Some Dates - Is Trouble Ahead?
Seeking Alpha
Sat, 03/7/15 - 11:18 am
Tags:
Vivus, Actavis, Qsymia
Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus
TheStreet.com
Sat, 02/21/15 - 09:44 am
Tags:
obesity, Orexigen, Arena, Vivus, Belviq, Contrave, Qsymia
Vivus' Qsymia Experiencing Both Prescription Growth And Market Share Erosion
Seeking Alpha
Wed, 02/18/15 - 10:52 am
Tags:
Vivus, Qsymia, obesity, Orexigen, Arena Pharmaceuticals, Contrave, Belviq
With Flat Qsymia Sales, Vivus May Shift Focus To Stendra/Spedra
Seeking Alpha
Fri, 02/6/15 - 08:08 am
Tags:
Vivus, Qsymia, Stendra, Spedra, erectile dysfunction
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
Tags:
obesity, Orexigen, Contrave, Arena Pharmaceuticals, Belviq, APD334, Vivus, Qsymia, EnteroMedics, devices, Maestro System, Novo Nordisk, Saxenda
Is Vivus Headed Towards An Unfortunate Ending?
Seeking Alpha
Mon, 12/29/14 - 11:10 am
Tags:
Vivus, Qsymia
Best and worst 2014 biotech performers on Wall Street
Fierce Biotech
Tue, 12/23/14 - 10:24 am
Tags:
Avanir Pharmaceuticals, Agios Pharmaceuticals, TG Therapeutics, Bluebird Bio, Vivus, Agerion, Theravance
Arena And Vivus Investors Need To Grasp Implications Of Orexigen
Seeking Alpha
Fri, 12/19/14 - 04:08 pm
Tags:
Arena Pharmaceuticals, Vivus, Contrave, Belviq, Qsymia
Vivus Tries To Lead Obesity Space With Insurance Coverage
Seeking Alpha
Tue, 12/16/14 - 08:18 am
Tags:
Vivus, obesity, insurance, Qsymia
VIVUS Announces Favorable Formulary Positioning for Qsymia
Yahoo
Mon, 12/15/14 - 08:01 am
Tags:
Vivus, Qsymia, formulary
Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals
Adam on Biotech Stocks
Fri, 12/12/14 - 12:33 pm
Tags:
obesity, Orexigen, Contrave, Arena Pharmaceuticals, Belviq, Vivus, Qsymia
The Odds Of Success For The New Obesity Drugs
CP Wire
Mon, 12/8/14 - 11:45 am
Tags:
obesity, Belviq, Contrave, Qsymia, Arena Pharmaceuticals, Vivus, Orexigen
Will Diabetes Drugs Enter The Anti-Obesity Space?
Seeking Alpha
Mon, 12/8/14 - 08:29 am
Tags:
diabetes, obesity, Arena Pharmaceuticals, Novo Nordisk, AstraZeneca, Orexigen, Vivus, Farxiga, Victoza, Invokana
Vivus awarded two patents for Qsymia
Seeking Alpha
Wed, 11/26/14 - 12:05 pm
Tags:
Vivus, Qsymia, patents
Why VIVUS (VVUS) Might Be a Diamond in the Rough
Yahoo/Zacks.com
Wed, 11/19/14 - 08:24 am
Tags:
Vivus
Arena And Vivus Investors Need To Watch Orexigen
Seeking Alpha
Tue, 11/11/14 - 10:38 am
Tags:
Arena Pharmaceuticals, Orexigen, Vivus, obesity
Vivus posts 3Q loss, results beat Street expectations
Yahoo/AP
Wed, 11/5/14 - 07:39 pm
Tags:
Vivus, earnings
3 Pharma Companies Fighting Obesity
Yahoo/Benzinga
Thu, 10/30/14 - 05:33 pm
Tags:
obesity, Orexigen, Arena, Vivus

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.